This signaling cascade results in the transcriptional alteration of genes critical for T cell effector functions, including the downregulation of interferon-gamma (IFN-γ) and granzyme B, while potentially upregulating inhibitory receptors like PD-1, thereby facilitating tumor immune evasion (91). The gene discussed is IFNG; the disease is neoplasm.